Artivion | CRY - Net Income


Artivion reported $2.42M in Net Income for its fiscal quarter ending in December of 2025.





Net Income Change Date
Abbott USD 920M 8M Sep/2026
Accuray USD 2.54M 6.49M Dec/2024
AngioDynamics USD -6.35M 4.55M Sep/2025
Artivion USD 2.42M 4.07M Dec/2025
AtriCure USD 4.06M 4.89M Sep/2026
Baxter International USD 294M 168M Sep/2026
Becton, Dickinson and Co. USD 696M 319M Sep/2026
Boston Scientific USD 582M 325M Sep/2026
Edwards Lifesciences USD 307.5M 65.6M Sep/2026
Inogen USD -5.96M 373K Sep/2024
Integra LifeSciences USD 14.85M 10.37M Sep/2026
J&J USD 210M 5.32B Sep/2026
Mesa Laboratories USD -1.68M 5.1M Dec/2024
Orthofix International USD -2.22M 20.57M Dec/2025
Pfizer USD 3.24B 3.49B Sep/2026
ResMed USD 383.43M 15.3M Jun/2026
Stryker USD 1.28B 531M Jun/2026
Tandem Diabetes Care USD -7.08M 14.08M Sep/2026
Teleflex USD 927.43M 827.73M Sep/2026
Terumo JPY 70.43B 44.06B Jun/2026
Trinity Biotech USD -4.39M 13.08M Mar/2026